TGTiago Severo Garcia

Tiago Severo Garcia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tiago Severo Garcia has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Adherence to drug treatment in children and adolescents with cystic fibrosis

    by Samantha Zamberlan Leyraud, Janaína Frescura Paim Bardini, Tiago Severo Garcia, Paulo José Cauduro Maróstica

    Introduction: To assess adherence to pharmacotherapy in pediatric patients with cystic fibrosis, associating it with socioeconomic, clinical, and nutritional variables. Methods: Cross-sectional study, including patients aged 0 to 18 with a diagnosis of cystic fibrosis. To assess adherence, the self-report questionnaire Brief Medication Questionnaire (BMQ) and medication withdrawals from the pharmacy over 12 months were used. The average medication possession rate (CMPR) was calculated for each patient and classified into two groups: high adherence (≥0.8) and moderate/low adherence (<0.8). The Shwachman-Kulczycki (SK) and Bhalla scores, spirometry, and nutritional diagnosis were obtained. Results: Of the 85 patients, 37.6% adhered to treatment according to the BMQ, and 64% according to the CMPR. The general analysis showed an association between CMPR and clinical score (p=0.013), Bhalla score (p=0.02), and better nutritional diagnosis (p=0.045). Dividing the groups by age, in the 0-5 age group there was an association between the family’s socioeconomic factor, the CMPR (p=0.017), and the BMQ (0.008). In the 6-18 age group, there was an association between the CMPR and the body mass index (BMI) Z-score (p=0.025) and SK (p=0.017). There was also an association between adherence to the BMQ and the belief barrier (p=0.022). There was also an association between the CMPR and the body mass index Z-score (p=0.017), and SK (p=0.025), and an association between adherence to the BMQ and the belief barrier (p=0.022). Conclusion: Adherence to drug treatment by self-reporting was lower than adherence by collecting the drugs from the pharmacy. The clinical score of SK, Bhalla, and the nutritional diagnosis were directly correlated with the CMPR. There was an influence of the socioeconomic factor in younger patients (<6 years), and for older patients (≥6 years) there was an influence of their belief barriers.

  • Open Access

    Association between abnormalities on chest computed tomography and pulmonary function in patients with respiratory symptoms at 12 months after COVID-19

    by Luciano Folador, Vicente Bohrer Brentano, Ravena Maya Cardoso da Silva, Igor Gorski Benedetto, Marcelo Basso Gazzana, Danilo Cortozi Berton, Tiago Severo Garcia

    Objective: To assess the prevalence and type of residual lung abnormalities on chest computed tomography (CT) and pulmonary function testing (PFT) variables in patients with respiratory symptoms related to post-COVID-19 condition at 12 months of follow-up, and to analyze associations between CT findings and PFT parameters. Materials and Methods: The CT findings were evaluated by two radiologists, who calculated semiquantitative CT scores. The PFTs included spirometry, plethysmography, and the diffusing capacity of the lung for carbon monoxide. Results: Thirty-seven patients were included in the study. On CT scans of the chest acquired at 12 months of follow-up, 78.3% of the patients exhibited residual abnormalities, including reticular opacities, in 75.7%; traction bronchiectasis/bronchiolectasis, in 43.2%; and fibrosis-like findings, in 43.2%. The mean overall CT score was 9.30 ± 2.59. Patients with fibrosis-like findings had significantly lower total lung capacity (68.6% vs. 80.6% of the predicted value; p = 0.018). A moderate negative correlation was found between the overall CT score and total lung capacity (rs = −0.49; p = 0.003). Conclusion: It seems that a significant proportion of patients with respiratory symptoms related to post–COVID-19 condition demonstrate residual lung abnormalities on chest CT at 12 months of follow-up, with a substantial prevalence of fibrosis-like findings. Such abnormalities are associated with restrictive lung disease.

  • Open Access

    Incidence of contrast-associated acute kidney injury: a prospective cohort

    by André Lucas Ribeiro, Fabricio Bergelt de Sousa, Beatriz Cavalcanti Juchem, André Zimerman, Guilherme Bernardi, Manoela Astolfi Vivan, Tiago Severo Garcia

    Introduction: Contrast-associated acute kidney injury (CA-AKI) is a deterioration of kidney function that occurs after the administration of a iodinated contrast medium (ICM). Most studies that defined this phenomenon used older ICMs that were more prone of causing CA-AKI. In the past decade, several articles questioned the true incidence of CA-AKI. However, there is still a paucity of a data about the safety of newer ICM. Objective: To assess the incidence of CA-AKI in hospitalized patients that were exposed to computed tomography (CT) with and without ICM. Methods: Prospective cohort study with 1003 patients who underwent CT in a tertiary hospital from December 2020 through March 2021. All inpatients aged > 18 years who had a CT scan during this period were screened for the study. CA-AKI was defined as a relative increase of serum creatinine of ≥ 50% from baseline or an absolute increase of ≥ 0.3 mg/dL within 18 to 48 hours after the CT. Chi-squared test, Kruskal-Wallis test, and linear regression model with restricted cubic splines were used for statistical analyses. Results: The incidence of CA-AKI was 10.1% in the ICM-exposed group and 12.4% in the control group when using the absolute increase criterion. The creatinine variation from baseline was not significantly different between groups. After adjusting for baseline factors, contrast use did not correlate with worse renal function. Conclusion: The rate of CA-AKI is very low, if present at all, with newer ICMs, and excessive caution regarding contrast use is probably unwarranted.


  • Open Access

    Incidência de lesão renal aguda associada ao contraste: uma coorte prospectiva

    by André Lucas Ribeiro, Fabricio Bergelt de Sousa, Beatriz Cavalcanti Juchem, André Zimerman, Guilherme Bernardi, Manoela Astolfi Vivan, Tiago Severo Garcia

    RESUMO Introdução: Lesão renal aguda associada ao contraste (LRA-AC) é uma deterioração da função renal que ocorre após a administração de meio de contraste iodado (MCI). A maioria dos estudos que definiram esse fenômeno utilizaram MCI mais antigos, mais propensos a causar LRA-AC. Na última década, diversos artigos questionaram a verdadeira incidência de LRA-AC. Entretanto, ainda há escassez de dados sobre a segurança dos MCI mais novos. Objetivo: Avaliar a incidência de LRA-AC em pacientes hospitalizados expostos à tomografia computadorizada (TC) com e sem MCI. Métodos: Estudo de coorte prospectivo com 1.003 pacientes submetidos a TC em hospital terciário, de dezembro/2020 a março/2021. Todos os pacientes internados com idade ≥ 18 anos que realizaram TC nesse período foram selecionados. A LRA-AC foi definida como aumento relativo de creatinina sérica de ≥ 50% em relação ao valor basal ou aumento absoluto de ≥ 0,3 mg/dL dentro de 18 a 48 horas após a TC. Utilizamos o teste qui-quadrado, teste de Kruskal-Wallis e modelo de regressão linear com splines cúbicos restritos para análises estatísticas. Resultados: A incidência de LRA-AC foi 10,1% no grupo exposto ao MCI e 12,4% no grupo controle ao usar o critério de aumento absoluto. A variação da creatinina em relação ao valor basal não foi significativamente diferente entre os grupos. Após ajuste para fatores basais, o uso de contraste não se correlacionou com pior função renal. Conclusão: A taxa de LRA-AC é muito baixa, caso exista, com MCIs mais novos, e a cautela excessiva quanto ao uso de contraste provavelmente não se justifica.

  • Open Access

    Respiratory mechanics characteristics at the time of barotrauma presentation in patients with critical COVID-19 infection

    by Gabriela Vieira Steckert, Sophia Andreola Borba, Gabriela Meirelles Marchese, Fabrício Schultz Medeiros, Tiago Severo Garcia, Marcio Manozzo Boniatti, Iuri Christmann Wawrzeniak

    Objective: To evaluate how ventilatory support, the duration of invasive ventilatory support use and lung mechanics are related to barotrauma development in patients who are severely infected with COVID-19 and who are admitted to the intensive care unit and develop pulmonary barotrauma. Methods: Retrospective cohort study of patients who were severely infected with COVID-19 and who developed pulmonary barotrauma secondary to mechanical ventilation. Results: This study included 60 patients with lung barotrauma who were divided into two groups: 37 with early barotrauma and 23 with late barotrauma. The early barotrauma group included more individuals who needed noninvasive ventilation (62.2% versus 26.1%, p = 0.01). The tidal volume/kg of predicted body weight on the day of barotrauma was measured, and 24 hours later, it was significantly greater in the late barotrauma group than in the early barotrauma group. During the day, barotrauma was accompanied by plateau pressure and driving pressure accompanied by tidal volume, which significantly increased in the late barotrauma group. According to the SAPS 3, patients in the early barotrauma group had more pulmonary thromboembolism and more severe illness. However, the intensive care unit mortality rates did not significantly differ between the two groups (66.7% for early barotrauma versus 76.9% for late barotrauma). Conclusion: We investigated the effect of respiratory mechanics on barotrauma in patients with severe COVID-19 and found that 25% of patients were on nonprotective ventilation parameters when they developed barotrauma. However, 50% of patients were on protective ventilation parameters, suggesting that other nonventilatory factors may contribute to barotrauma.

  • Open Access

    Características da mecânica respiratória na apresentação do barotrauma em pacientes com infecção grave pela COVID-19

    by Gabriela Vieira Steckert, Sophia Andreola Borba, Gabriela Meirelles Marchese, Fabrício Schultz Medeiros, Tiago Severo Garcia, Marcio Manozzo Boniatti, Iuri Christmann Wawrzeniak

    RESUMO Objetivo: Avaliar como o suporte ventilatório, o tempo de uso do suporte ventilatório invasivo e a mecânica pulmonar estão relacionados ao desenvolvimento de barotrauma em pacientes com infecção grave pela COVID-19 admitidos na unidade de terapia intensiva. Métodos: Trata-se de estudo de coorte retrospectivo de pacientes com infecção grave pela COVID-19 que desenvolveram barotrauma pulmonar secundário à ventilação mecânica. Resultados: Este estudo incluiu 60 pacientes com barotrauma pulmonar divididos em dois grupos: 37 com barotrauma precoce e 23 com barotrauma tardio. O grupo com barotrauma precoce incluiu mais indivíduos que precisaram de ventilação não invasiva (62,2% versus 26,1%, p = 0,01). O volume corrente/kg de peso corporal previsto no dia do barotrauma foi medido e, 24 horas depois, foi significativamente maior no grupo com barotrauma tardio do que no grupo com barotrauma precoce. Durante o dia, o barotrauma foi acompanhado pela pressão de platô e pela pressão de distensão acompanhada do volume corrente, o qual aumentou significativamente no grupo com barotrauma tardio. De acordo com o SAPS 3, os pacientes do grupo com barotrauma precoce apresentaram mais tromboembolia pulmonar e doença mais grave. Entretanto, as taxas de mortalidade na unidade de terapia intensiva não diferiram significativamente entre os dois grupos (66,7% para barotrauma precoce versus 76,9% para barotrauma tardio). Conclusão: Investigamos o efeito da mecânica respiratória no barotrauma em pacientes com COVID-19 graves e descobrimos que um quarto dos pacientes estava em parâmetros de ventilação não protetores quando desenvolveram barotrauma. No entanto, 50% dos pacientes estavam em parâmetros de ventilação protetora, sugerindo que outros fatores não ventilatórios podem contribuir para o barotrauma.

  • Open Access

    Impact of impaired pulmonary function on clinical outcomes in survivors of severe COVID-19 without pre-existing respiratory disease

    by Igor Gorski Benedetto, Ravena Maya Cardoso da Silva, Guilherme Moreira Hetzel, Gabriel da Silva Viana, Amanda Reis Guimarães, Luciano Folador, Vicente Bohrer Brentano, Tiago Severo Garcia, Sergio Pinto Ribeiro, Paulo de Tarso Roth Dalcin, et al.

    Objective: To investigate the impact of impaired pulmonary function on patient-centered outcomes after hospital discharge due to severe COVID-19 in patients without preexisting respiratory disease. Methods: This is an ongoing prospective cohort study evaluating patients (> 18 years of age) 2-6 months after hospital discharge due to severe COVID-19. Respiratory symptoms, health-related quality of life, lung function, and the six-minute walk test were assessed. A restrictive ventilatory defect was defined as TLC below the lower limit of normal, as assessed by plethysmography. Chest CT scans performed during hospitalization were scored for the presence and extent of parenchymal abnormalities. Results: At a mean follow-up of 17.2 ± 5.9 weeks after the diagnosis of COVID-19, 120 patients were assessed. Of those, 23 (19.2%) reported preexisting chronic respiratory diseases and presented with worse lung function and exertional dyspnea at the follow-up visit in comparison with their counterparts. When we excluded the 23 patients with preexisting respiratory disease plus another 2 patients without lung volume measurements, a restrictive ventilatory defect was observed in 42/95 patients (44%). This subgroup of patients (52.4% of whom were male; mean age, 53.9 ± 11.3 years) showed reduced resting gas exchange efficiency (DLCO), increased daily-life dyspnea, increased exertional dyspnea and oxygen desaturation, and reduced health-related quality of life in comparison with those without reduced TLC (50.9% of whom were male; mean age, 58.4 ± 11.3 years). Intensive care need and higher chest CT scores were associated with a subsequent restrictive ventilatory defect. Conclusions: The presence of a restrictive ventilatory defect approximately 4 months after severe COVID-19 in patients without prior respiratory comorbidities implies worse clinical outcomes.


  • A Prototype Implantable Artificial Bronchus Reduces Lung Hyperinflation in Recently Deceased Patients with Emphysema

    by Hugo Goulart de Oliveira, Amarilio Macedo-Neto, Maurício Saueressig, Paulo Sanches, Léa Fialkow, Edino Parolo, Fabiano Nagel, Tiago Garcia, Patricia Rieken Macedo Rocco

    Background: Several minimally invasive treatments have been offered to patients with severe emphysema over the last two decades. Currently, endobronchial valves (EBVs) are the only approved therapeutic option, but this method has drawbacks: only a few can undergo this therapy and the incidence of pneumothorax remains high. A minimally invasive technique, appropriate for a broader patient population and posing fewer risks, would represent a desirable alternative to improve lung function in these patients. Objective: The objective of this study was to demonstrate whether a new prototype implantable artificial bronchus (IAB) releases trapped air from the lungs of recently deceased patients with emphysema. Method: Seven recently deceased patients with emphysema were mechanically ventilated and the respiratory rate increased from 12 bpm (resting) to 30 bpm (exercise), inducing air trapping and dynamic hyperinflation. This protocol was performed twice, before and after IAB placement. Ventilation parameters and the fraction of inspired oxygen were similar in all patients. Respiratory system plateau pressure (Pplat,rs) and intrinsic positive end-expiratory pressure (iPEEP) were measured. Results: IAB implantation significantly reduced Pplat,rs (p = 0.017) in 6 of 7 deceased patients with emphysema and iPEEP (p = 0.03) in 5 of 7 patients. Conclusions: Placement of one or two IABs in segmental bronchi (up to 15th generation) proved to be feasible and improved lung function. These findings should provide a basis for subsequent clinical studies to assess the safety and efficacy of IAB in patients with emphysema, as well as identify short- and long-term effects of this innovative procedure.


  • Open Access

    Diagnostic accuracy of multiorgan point-of-care ultrasound compared with pulmonary computed tomographic angiogram in critically ill patients with suspected pulmonary embolism

    by Adriana M. Girardi, Eduardo E. Turra, Melina Loreto, Regis Albuquerque, Tiago S. Garcia, Tatiana H. Rech, Marcelo B. Gazzana

    Background: Critically ill patients have a higher incidence of pulmonary embolism (PE) than non-critically ill patients, yet no diagnostic algorithm has been validated in this population, leading to the overuse of pulmonary artery computed tomographic angiogram (CTA). This study aimed to comparatively evaluate the diagnostic accuracy of point-of-care ultrasound (POCUS) combined with laboratory data versus CTA in predicting PE in critically ill patients. Methods: A prospective diagnostic accuracy study. Critically ill patients with suspected acute PE undergoing CTA were prospectively enrolled. Demographic and clinical data were collected from electronic medical records. Blood samples were collected, and the Wells and revised Geneva scores were calculated. Standardized multiorgan POCUS and CTA were performed. The discriminatory power of multiorgan POCUS combined with biochemical markers was tested using ROC curves, and multivariate analysis was performed. Results: A total of 88 patients were included, and 37 (42%) had PE. Multivariate analysis showed a relative risk (RR) of PE of 2.79 (95% CI, 1.61–4.84) for the presence of right ventricular (RV) dysfunction, of 2.54 (95% CI, 0.89–7.20) for D-dimer levels >1000 ng/mL, and of 1.69 (95% CI, 1.12–2.63) for the absence of an alternative diagnosis to PE on lung POCUS or chest radiograph. The combination with the highest diagnostic accuracy for PE included the following variables: 1– POCUS transthoracic echocardiography with evidence of RV dysfunction; 2– lung POCUS or chest radiograph without an alternative diagnosis to PE; and 3– plasma D-dimer levels >1000 ng/mL. Combining these three findings resulted in an area under the curve of 0.85 (95% CI, 0.77–0.94), with 50% sensitivity and 96% specificity. Conclusions: Multiorgan POCUS combined with laboratory data has acceptable diagnostic accuracy for PE compared with CTA. The combined use of these methods might reduce CTA overuse in critically ill patients.


  • Open Access

    Development of a customized three-dimensional airway model

    by Mateus Samuel Tonetto, Hugo Goulart de Oliveira, Andre Frotta Muller, Paulo Roberto Stefani Sanches, Luciano Folador, Felipe Soares Torres, Tiago Severo Garcia

    This study aimed to develop a customized, three-dimensional airway model based on relevant medical images, using additive manufacturing techniques. We evaluated the model’s ability to replicate the dimensions of the images acquired from the chest of a patient using multi-detector computed tomography (CT). Using dedicated software, a three-dimensional mesh was created based on the images. A multi-detector CT study of the full-scale printed three-dimensional airways model was subsequently carried out to compare its dimensions with that of the original study at four predetermined points. The observed median differences at the four points were 0.4 mm (p = 0.686), -1.3 mm (p = 0.138), 0.7 mm (p = 0.141), and 0.1 mm (p = 0.892). The intraclass correlation coefficient between the measurements made on the patient and those on the model was 0.98 (95% confidence interval: 0.96–0.99, p < 0.001). We successfully developed a three-dimensional model of the airway based on its corresponding medical images. The differences in the dimensions between the model and the original images were in line with those observed in previous studies and are presumably irrelevant for most applications.